The beautiful science of embryology
By Kate Womersley,
Prospect
| 03. 03. 2021
It’s a familiar story: the virile sperm fights its path through the hostile uterus to the passive female egg. After fertilisation, the resulting ball of cells is “totipotent,” with each unit equally capable of becoming any cell type in the placenta or foetus. Magdalena Zernicka-Goetz, an embryologist from the University of Cambridge, affronted her field by claiming this was wrong: not just the sexist metaphors, but also the assumption that the first human cells are identical. Her experiments showed that cells lean towards a particular fate, and that an embryo’s symmetry is broken from its earliest moments.
Together with science journalist Roger Highfield, Zernicka-Goetz leads us through the intricacies of modern embryology and reproductive technology. Her successes include doubling the length of time embryos can survive in the lab, building simulation mouse embryos out of stem cells and using fluorescent labels to make “embryo art.” “We are entering a new era,” she writes, “one where we can manipulate the cellular units of life as skilfully as a potter works clay.” While gene editing and designer babies raise understandable alarm, artistry...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...